Bioverativ
Bioverativ is a global biotechnology company developing therapies for hemophilia and other rare blood disorders, including sickle cell disease and beta-thalassemia.
Acquirer
B2X
0
CAGE Code
7WTM8
0
CIK Number
Company Operating Status
Active
Country
DUNS Number
080485797
0
Founded Date
2017
0
Full Address
225 2nd Ave, Waltham, MA 02451, US
0
IRS Number
813,461,310
0
LinkedIn URL
Location
Number of Employees (Ranges)
201 – 500
0
Parent Organization
Patents Assigned (Count)
52
Pitchbook URL
Place of Incorporation
Public/Private
Public
0
SIC Code
2,834
0
Spun Out From
Official Website
Wikidata ID
Find more companies like Bioverativ
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.